NTI | bio this week released a new AIxBio Horizon Scan, an assessment designed to help policymakers, industry leaders, and researchers anticipate fast‑moving advances at the intersection of artificial intelligence and the life sciences.
The AIxBio Horizon Scan examines emerging capabilities expected over the next six to 18 months and highlights trends that could significantly shape both opportunity and risk. With AIxBio tools advancing faster than many experts predicted, the report provides early insights to support stronger safety, security, and governance decisions.
Key findings include:
The horizon scan is designed to help industry insiders and policymakers make well-informed decisions about how to get ahead of the risks and ensure that AIxBio capabilities are used responsibly.
NTI | bio plans to publish updated Horizon Scans every six months to provide regular, forward‑looking analysis of the AIxBio landscape. This work supports NTI’s broader mission to reduce emerging biological risks and ensure that powerful emerging technologies are used responsibly.
Read the AIxBio Horizon Scan here.
Sign up for our newsletter to get the latest on nuclear and biological threats.
NTI | bio convened global experts for the 2025 Biosecurity Innovation Risk Reduction Initiative (BIRRI) meeting to discuss safeguarding rapidly advancing bioscience and biotechnology capabilities, focusing on three key areas: DNA synthesis screening, safeguarding AIxBio capabilities, and guarding against mirror life risks.
NTI | bio has responded to the U.S. government request for information (RFI) related to the Artificial Intelligence (AI) Action Plan outlined by President Donald Trump’s January 2025 Executive Order, providing input on the highest priority actions to maintain and extend U.S. global leadership on AI.
The official side event focused on safeguarding capabilities at the convergence of AI with the life sciences.
Sign up for regular updates on innovative, real-world solutions to existential threats.
